Instant NanoBiosensors' FOPPR Enhancement Assay was used in the rapid (<15 min) and ultrasensitive (fM) detection of procalicitonin (PCT), an important biomarker for sepsis. In addition to the short detection time and ultrasensitivity, the FOPPR Enhancement Assay also offers a wide linear response range (5 orders) and good correlation in determining plasma PCT with the clinically validated immunoassay, demonstrating its potential to be used as a point-of-care testing tool. The research paper was recently published in Biosensors and Bioelectronics, a peer-reviewed scientific journal first in the field of analytical chemistry with an impact factor of 9.5!
The CEO of Instant NanoBiosensors was recently interviewed by H. Spectrum, a startup incubator and accelerator focusing on the healthcare sector:https://medium.com/hspectrum/light-saves-lives-%E5%85%A8%E7%90%83%E9%A6%96%E5%89%B5%E5%85%89%E7%BA%96-%E5%A5%88%E7%B1%B3-%E5%BE%AE%E6%B5%81%E9%AB%94%E7%9A%84%E7%94%9F%E7%89%A9%E6%84%9F%E6%B8%AC%E5%84%80-%E9%A1%9B%E8%A6%86%E8%A8%BA%E6%96%B7%E5%B8%82%E5%A0%B4-%E5%B0%88%E8%A8%AA%E5%A5%88%E6%8D%B7%E7%94%9F%E6%8A%80instant-nanobiosensors-110c2eb8a39c
With its innovative Biomarker Analyzer, Instant NanoBiosensors is attracting attention from international pharmaceutical companies and research institutions as a collaborative partner in companion diagnostics and clinical research while expanding its global distributors network.Related news: https://www.bnext.com.tw/article/54674/instantnanobiosensors
The CEO of Instant NanoBiosensors took part in H. Spectrum's Entrepreneur Night to talk about how the Biomarker Analyzer can assist in patient diagnostics and disease management for long-term elderly care as part of the aging global society.Related news: https://buzzorange.com/techorange/2019/08/29/instant-nanobiosensors-helios-bioelectronics-vsense-molsentech/https://www.facebook.com/513543122133911/posts/1368902406597974?sfns=mo
The CEO of Instant NanoBiosensors, Tony Chung, was recently interviewed by Pharma Boardroom to talk about the potential of the FOPPR technology, the commercialization strategy of the Biomarker Analyzer INB-D200, and the advantages of being a Taiwanese diagnostics device startup!Interview feature: https://pharmaboardroom.com/interviews/tony-chung-ceo-co-founder-instant-nanobiosensors-taiwan/
Contact
Us
Share
